Figure 1From: Benign elevations in serum aminotransferases and biomarkers of hepatotoxicity in healthy volunteers treated with cholestyramine The study design. Subjects were administered placebo from day 1 to 12 of the study or placebo from day 1 to 12 and single dose 400 mg Moxifloxacin (Moxi) on day 12, followed by a washout phase with cholestyramine from day 13 to 23.Back to article page